We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > DirectedLuck

News List

ProBioGen Was Granted a New Patent for DirectedLuck® Transposase Technology B3C newswire
January 17, 2024
ProBioGen announced today that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck® technology.
Asher Bio, ProBioGen Ink Development, Mfg. Agreement contractpharma
April 27, 2021
ProBioGen to provide cell line development, process development and GMP manufacturing at 1000 L bioreactor scale of Asher's lead immuno-oncology candidate.
DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development b3cnewswire
November 13, 2019
ProBioGen AG, a premier German service & technology provider for complex biologics, announced the launch of DirectedLuck, a highly active transposase equipped for specific epigenetic targeting.